In vitro study demonstrates that Sesbania cannabina root polysaccharide protects liver cells from ethanol injury, indicating therapeutic potential for liver disease.
This study investigated the structural characteristics, conformational features, and hepatoprotective activity of a polysaccharide (SCPC-2) isolated from the roots of Sesbania cannabina , an underutilized industrial crop widely distributed in saline-alkaline regions. SCPC-2 exhibited an average molecular weight of 7.97 kDa and was composed mainly of mannose, galactose, rhamnose, glucose, arabinose, glucuronic acid, and galacturonic acid. Methylation analysis revealed that SCPC-2 contained diverse glycosidic linkages, including t-Man(p), t-Gal(p), t-Glc(p), and various branched residues, indicating a structurally complex architecture. NMR spectroscopy revealed characteristic oxygenated sugar-ring signals and representative H/C correlations, supporting the general carbohydrate structural features of SCPC-2. In vitro cell model assays demonstrated that SCPC-2 significantly improved the viability of ethanol-injured HepG2 cells. It reduced the levels of transaminases (ALT and AST) and the lipid peroxidation product MDA, while elevating the levels of antioxidants (SOD and GSH) and ethanol metabolism-related enzymes (ADH and ALDH). Mechanistic studies indicated that SCPC-2 alleviated ethanol-induced HepG2 cell damage by coordinately regulating ethanol metabolism and enhancing antioxidant defense via activation of the Keap1-Nrf2/HO-1 signaling pathway. These findings suggest that SCPC-2 may be a promising hepatoprotective agent, highlighting the potential for high-value utilization of S. cannabina roots.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: